Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 46, Issue 1, 2002, Pages 175-190

  Gergely Jr , Peter ^a   Grossman, Craig ^a   Niland, Brian ^a   Puskas, Ferenc ^a   Neupane, Hom ^a   Allam, Fatme ^a   Banki, Katalin ^a   Phillips, Paul E ^a   Perl, Andras ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CD28 ANTIGEN; CD3 ANTIGEN; GLUTATHIONE; HYDROGEN PEROXIDE; LIPOCORTIN 5; OLIGOMYCIN; PROPIDIUM IODIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MALE; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; FEMALE; FLOW CYTOMETRY; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; HYDROGEN PEROXIDE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MITOCHONDRIA; NECROSIS; OXIDANTS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

EID: 0036161789     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H     Document Type: Article

References (85)

1. Apoptosis in SLE: Too little or too much?
2. Molecular mimicry, altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus
3. Apoptosis and programmed cell death in immunity
4. Apoptosis in the pathogenesis and treatment of disease
5. The Fas death factor
6. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
7. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
8. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
9. The apoptosis-1/Fas protein in human systemic lupus erythematosus
10. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-α
11. Spontaneous and induced apoptosis in systemic lupus erythematosus: Multiple assays fail to reveal consistent abnormalities
12. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
13. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
14. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation
15. Hydrogen peroxide as a potent activator of T lymphocyte functions
16. Reactive oxygen species regulate activation-induced T cell apoptosis
17. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
18. Regulators of cell death
19. Oxidative stress as a mediator of apoptosis
20. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression
21. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α
22. Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells
23. Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death
24. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
25. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils
26. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas
27. - synthesis
28. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway
29. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling
30. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis
31. L regulates the membrane potential and volume homeostasis of mitochondria
32. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C
33. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by bcl-2
34. L prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor α-induced apoptosis
35. Changes in mitochondrial membrane potential during staurosporin-induced apoptosis in Jurkat cells
36. Role of free radicals and catalytic metal ions in human disease: An overview
37. Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells, and organisms
38. The 1982 revised criteria for the classification of systemic lupus erythematosus
39. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
40. Derivation of the SLEDAI: A disease activity index for lupus patients
41. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells
42. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V
43. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of bcl-2 and Abl
44. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
45. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications
46. Flow cytometric analysis of altered mononuclear cell transmembrane potential induced by cyclosporin
47. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming cation JC-1
48. Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells: The role of mitochondria
49. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites
50. Protein measurement with the Folin phenol reagent
51. ATP extractants neutralised by cyclodextrins
52. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
53. High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives
54. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand
55. The pentose phosphate pathway and other pathways of hexose metabolism
56. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
57. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
58. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
59. Farnesol-induced generation of reactive oxygen species dependent on mitochondrial transmembrane potential hyperpolarization mediated by F(0)F(1)-ATPase in yeast
60. The T cell enigma in lupus
61. Immune cell signaling defects in lupus: Activation, anergy and death
62. Differential expression of apoptosis related Fas antigen on lymphocyte subpopulations in human peripheral blood
63. Fas transduces activation signals in normal human T lymphocytes
64. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice
65. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases
66. Tumour necrosis factor a and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus
67. Cytokine production (IL-6 and TNFα) in whole blood cell cultures of patients with systemic lupus erythematosus
68. Cytokines in the immunopathogenesis of lupus
69. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC, PTK, bcl-2, and Fas
70. Requirement of cysteine-rich repeats of the Fas receptor for binding of the Fas ligand
71. Cell surface trafficking of Fas: A rapid mechanism of p53-induced apoptosis
72. Regulation of Fas ligand expression during activation-induced cell death in T lymphocytes
73. Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
74. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases
75. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity
76. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus
77. Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine
78. Advances in immunology: Complement
79. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens
80. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression
81. More than one way to die: Apoptosis, necrosis and reactive oxygen damage
82. Morphology of bone marrow in systemic lupus erythematosus [German]
83. Fine needle aspiration cytology in lupus lymphadenopathy: A case report
84. Necrotizing lymphadenitis associated with systemic lupus erythematosus